Editorial: Methods in alloimmunity and transplantation: 2023

Guido Moll; Andreas Beilhack

doi:10.3389/fimmu.2024.1516554

Editorial: Methods in alloimmunity and transplantation: 2023

Front Immunol. 2024 Nov 11:15:1516554. doi: 10.3389/fimmu.2024.1516554. eCollection 2024.

Authors

Guido Moll^{1

2

3

4}, Andreas Beilhack⁵

Affiliations

¹ BIH Center for Regenerative Therapies (BCRT).
² Berlin-Brandenburg School for Regenerative Therapies (BSRT).
³ Julius Wolff Institute (JWI) for Musculoskeletal Research.
⁴ Department of Nephrology and Internal Intensive Care Medicine, all three part of Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
⁵ Experimental Stem Cell Transplantation Group, Departments of Internal Medicine II and Department of Pediatrics, University Hospital Würzburg, Center of Experimental Molecular Medicine, Würzburg, Germany.

No abstract available

Keywords: alloimmunity; cell therapy; immunomodulation; immunosuppression; inflammation; methods/technology; rejection; transplantation.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AB was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – project number 324392634 – TRR 221. GM was supported by grants from the German Federal Ministry of Education and Research (BMBF) and the DFG (EXPAND-PD project #CA2816/1) and through the BIH Center for Regenerative Therapies (BCRT) and the Berlin-Brandenburg School for Regenerative Therapies (BSRT: GSC203), respectively, and in part by the European Union’s Horizon 2020 Research and Innovation Program und the grant agreements No 733006 (PACE), 779293 (HIPGEN), 754995 (EU-TRAIN), and 101095635 (PROTO). We acknowledge financial support from the Open Access Publication Fund of Charité Universitätsmedizin Berlin and the DFG.